Using AI to personalise drug combination therapy

Doctors routinely employ a combination therapy strategy for cancer patients, but figuring out which drugs to use is a challenge. Researchers at the National University of Singapore have developed an artificial intelligence platform called QPOP to streamline this process. Abi Millar finds out more about how the platform could personalise combination therapy.

2018-10-01T12:20:06+01:00 16 October 2018|Health|